Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer. | Front Genet | 2021 | 34267780 | PubTator, text mining | PubMed |
| Implementing information and communication technology education on food allergy and anaphylaxis in the school setting. | Clin Transl Allergy | 2021 | 34262693 | PubTator, text mining | PubMed |
| FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation. | Adv Radiat Oncol | 2021 | 34258475 | PubTator, text mining | PubMed |
| Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. | Genet Med | 2021 | 34257420 | PubTator, text mining | PubMed |
| FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | Dev Cell | 2021 | 34256011 | PubTator, text mining | PubMed |
| A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer. | J Gastroenterol | 2021 | 34255164 | PubTator, text mining | PubMed |
| Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants. | JCO Precis Oncol | 2021 | 34250406 | PubTator, text mining | PubMed |
| Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies. | Front Oncol | 2021 | 34249714 | PubTator, text mining | PubMed |
| The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma. | J Transl Med | 2021 | 34247626 | PubTator, text mining | PubMed |
| Normalisation of the psychometric encephalopathy score within the Cameroonian population. | BMC Gastroenterol | 2021 | 34247589 | PubTator, text mining | PubMed |
| A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries. | Oncol Ther | 2021 | 34236692 | PubTator, text mining | PubMed |
| Neurophysiology of slip sensation and grip reaction: insights for hand prosthesis control of slippage. | J Neurophysiol | 2021 | 34232750 | PubTator, text mining | PubMed |
| Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. | FEBS Open Bio | 2021 | 34231338 | PubTator, text mining | PubMed |
| Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities. | Oncogene | 2021 | 34230613 | PubTator, text mining | PubMed |
| DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations. | Front Genet | 2021 | 34220964 | PubTator, text mining | PubMed |
| Targeting the replication stress response through synthetic lethal strategies in cancer medicine. | Trends Cancer | 2021 | 34215565 | PubTator, text mining | PubMed |
| DNA double-strand break repair gene mutation and the risk of papillary thyroid microcarcinoma: a case-control study. | Cancer Cell Int | 2021 | 34215272 | PubTator, text mining | PubMed |
| Acute Zonal Occult Outer Retinopathy (AZOOR) Results from a Clinicopathological Mechanism Different from Choriocapillaritis Diseases: A Multimodal Imaging Analysis. | Diagnostics (Basel) | 2021 | 34209956 | PubTator, text mining | PubMed |
| Withaferin A Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress. | Antioxidants (Basel) | 2021 | 34209212 | PubTator, text mining | PubMed |
| Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. | Int J Mol Sci | 2021 | 34208339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=68